Organogenesis Holdings Inc Class A (ORGO)
EBITDA Margin
-0.40%
TTM · Period ending:
ORGO EBITDA Margin
Latest reported-0.40%period ending
Latest reported-0.40%period ending
ORGO TTM EBITDA Margin (-341.66% → -0.40%)
TTM ebitda margin
High-resolution chart · PNG
ORGO ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -0.3962% | |
| 7.2639% | |
| 13.1268% | |
| 4.3219% | |
| 0.6129% | |
| -0.4163% | |
| 3.6789% | |
| 2.664% | |
| 2.9612% | |
| 8.3192% | |
| 8.3183% | |
| 8.532% | |
| 6.7598% | |
| 7.0106% | |
| 7.7267% | |
| 10.093% | |
| 13.3366% | |
| 16.026% | |
| 18.7365% | |
| 19.4016% | |
| 21.6151% | |
| 17.3577% | |
| 11.1623% | |
| 4.6398% | |
| -6.6446% | |
| -8.4623% | |
| -8.3753% | |
| -28.1608% | |
| -35.9173% | |
| -51.8126% | |
| -82.1963% | |
| -73.6043% | |
| -82.7758% | |
| -71.8346% | |
| -57.5618% | |
| -5,683.5554% | |
| -1,036.4482% | |
| -674.1471% | |
| -341.6574% |